Français
Search this site:
Symbol
Last
Change
IPN.PA
22.05 €
(+1.59 % )
powered by Euronext©
The Group
Profile & Key figures
Message from the Chairman
Group history
R & D
R & D Homepage
Neurology
Endocrinology
Oncology
Primary care
Medicines
Governance
Board of directors
Executive committee
Board committees
Compensation of corporate officers
Business Development & Alliance Management
Ipsen worldwide
Targeted diseases
Neurology
Endocrinology
Oncology
Hematology
Primary care
Commitments
Vision, mission and values
Environment, health and safety
Ethics and compliance
Support to Patient Organizations
Solidarity
Fondation IPSEN
La Fondation Ipsen at a glance
Colloques, prizes, publications
Neurosciences
Alzheimer’s disease
Endocrinology
Cancer science
Longevity
Vascular
Partnerships
Salk Institute - Nature
Cell Press - Massachusetts General Hospital
Nature Publishing Group
Home
>
Investor relations
> Financial results
Financial results
Ipsen shares
ADR Program
Financial calendar
Financial results
Conferences & Roadshows
General meeting
Regulated information
RSS Feed
You can choose the financial results by year :
All
2006
2007
2008
2009
2010
2011
2012
Paris (France)
-
02 February 2012
Ipsen's fourth quarter and full year 2011 sales and other significant developments
Download
Paris (France)
-
02 February 2012
Ipsen's fourth quarter and full year 2011 sales and other significant developments
Download
Go to
Press room
Investor relations
Careers
Ipsen’s fourth quarter and full year 2011 sales
2 February 2012
- Paris
Webcast
Presentation
Registration Document 2010
Download
Publications
Registration document 2010
2010 key figures and strategy project
Registration Document 2009
CONTACT US
Investor Relations
Tel.: +33 (0)1 58 33 51 29
Fax: +33 (0)1 58 33 50 63
Send an e-mail